12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Other News

PrimeraDx, National Cancer Institute pharmacogenetics news

PrimeraDx received a grant from the institute's Innovative Molecular Analysis Technologies program to develop an assay to rapidly...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >